Skip to Main Content

3,375

Views

0

CrossRef citations to date

0

Altmetric

Urology

Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis

Phil McEwana Health Economics and Outcomes Research Ltd, Cardiff, UKCorrespondence[email protected]
View further author information

,

Marco Hafnera Health Economics and Outcomes Research Ltd, Cardiff, UKView further author information

,

Vivekenand Jhab George Institute for Global Health India, New Delhi, IndiaView further author information

,

Ricardo Correa-Rotterc Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, MexicoView further author information

,

Gil Chernind Kaplan Medical Centre, Rehovet, IsraelView further author information

,

Luca De Nicolae University L. Vanvitelli-Dept. Advanced Medical and Surgical Sciences, Naples, ItalyView further author information

,

Russell Villanuevaf Department of Adult Nephrology, National Kidney and Transplant Institute, Quezon City, PhilippinesView further author information

,

David C. Wheelerg Department of Renal Medicine, University College London, London, UKView further author information

,

Salvatore Baroneh Global Medical Affairs, AstraZeneca, Gaithersburg, Maryland, United StatesView further author information

,

Stephen Nolani Global Medical Affairs, AstraZeneca, Cambridge, UKView further author information

&

Juan Jose Garcia Sanchezj Health Economic and Payer Evidence, AstraZeneca, Cambridge, UK

https://orcid.org/0000-0001-6546-7769 View further author information